Physician
Alexander Chehrazi-Raffle, M.D.
According to 2025 Medicare claims, Alexander Chehrazi-Raffle, M.D. (NPI: 1891157889) practices medical oncology in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is CITY OF HOPE MEDICAL FOUNDATION (NPI: 1871886366; TIN: 274803222) and primary practice location at 91010-3012.
Chehrazi-Raffle's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 316 traditional Medicare patients, billed 1,115 HCPCS/CPT codes, and received $112,492 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 859 prescription claims across 147 beneficiaries totaling $3,884,875 in drug costs, led by Erleada (Apalutamide). 2020 DME data shows 104 claims. Open Payments data shows 52 records totaling $47,453. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.
Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $6,597 to $3,884,875. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.